Market Cap 158.53M
Revenue (ttm) 4.06M
Net Income (ttm) -50.22M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,236.95%
Debt to Equity Ratio 0.00
Volume 186,300
Avg Vol 336,754
Day's Range N/A - N/A
Shares Out 32.29M
Stochastic %K 77%
Beta 1.63
Analysts Sell
Price Target $8.33

Company Profile

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The compa...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 949 409 7600
Address:
2 International Plaza Dr., Suite 510, Nashville, United States
jackedmund99
jackedmund99 May. 5 at 5:52 PM
$IMDX Refinitiv/Verus is a high-performing, quantitative independent research firm- this clown firm put a sale on Stock yesterday while it was going up a dollar it’s a quantitative research company. They have no foresight no intuition. They look at everything from quantitative analytical viewpoint obviously not doing a deep dive not talking to anybody just purely odd numbers so in the grand scheme of things they’re irrelevant.
0 · Reply
jackedmund99
jackedmund99 May. 5 at 5:48 PM
$IMDX huge volume yesterday whoever’s buying is letting it drift down and the little guys get out. Let let it fall. I believe they’ll be back closer to 4 1/4.
0 · Reply
WarrenPsnik
WarrenPsnik May. 5 at 2:23 PM
$IMDX Starter at $4.80 … (25%), long. Will look to add more on weakness (if there is) eyeing closer to $4.20 average
0 · Reply
StockScanners
StockScanners May. 5 at 5:25 AM
$IMDX keep watch if this holds above 4.98
0 · Reply
RUNNINWILD
RUNNINWILD May. 5 at 4:26 AM
$IMDX https://stocks.apple.com/AVpkzXASkQLalf1EDJGT4bg
0 · Reply
RUNNINWILD
RUNNINWILD May. 5 at 4:20 AM
$IMDX steady now, lads
0 · Reply
topstockalerts
topstockalerts May. 4 at 8:31 PM
$IMDX this is quietly putting in work while everything else chops
0 · Reply
RETAlerts
RETAlerts May. 4 at 8:29 PM
Interesting timing on $IMDX. HVAC content strategy gaining traction, catalyst driving the move. +5.2% on real engagement metric...
0 · Reply
Bogwood
Bogwood May. 4 at 8:16 PM
$IMDX such a solid close!! Highest vol since the times square rebranding day
0 · Reply
InvestingSpaceman
InvestingSpaceman May. 4 at 7:40 PM
$MNDR $CCM $IMDX why not
0 · Reply
Latest News on IMDX
iMDx to Release First Quarter 2026 Results on May 13, 2026

May 6, 2026, 4:05 PM EDT - 6 days ago

iMDx to Release First Quarter 2026 Results on May 13, 2026


Insight Molecular Diagnostics Earnings Call Transcript: Q4 2025

Mar 26, 2026, 5:00 PM EDT - 6 weeks ago

Insight Molecular Diagnostics Earnings Call Transcript: Q4 2025


iMDx Announces $26.0 Million Registered Direct Offering

Feb 11, 2026, 8:00 AM EST - 3 months ago

iMDx Announces $26.0 Million Registered Direct Offering


iMDx prepares for U.S. commercial launch of GraftAssureDx

2026-01-05T12:11:39.000Z - 4 months ago

iMDx prepares for U.S. commercial launch of GraftAssureDx


Insight Molecular Diagnostics Earnings Call Transcript: Q3 2025

Nov 10, 2025, 5:00 PM EST - 6 months ago

Insight Molecular Diagnostics Earnings Call Transcript: Q3 2025


Insight Molecular Diagnostics announces novel registry database

2025-09-08T11:25:06.000Z - 8 months ago

Insight Molecular Diagnostics announces novel registry database


Insight Molecular Diagnostics Transcript: KOL event

Aug 15, 2025, 4:00 PM EDT - 9 months ago

Insight Molecular Diagnostics Transcript: KOL event


Insight Molecular Diagnostics Earnings Call Transcript: Q2 2025

Aug 11, 2025, 5:00 PM EDT - 9 months ago

Insight Molecular Diagnostics Earnings Call Transcript: Q2 2025


Oncocyte Reports Q1 2025 Results and Business Progress

May 12, 2025, 4:05 PM EDT - 1 year ago

Oncocyte Reports Q1 2025 Results and Business Progress


Oncocyte Provides Positive Update on Clinical Trial Progress

Apr 30, 2025, 8:30 AM EDT - 1 year ago

Oncocyte Provides Positive Update on Clinical Trial Progress


Oncocyte Expands Market Opportunity for VitaGraft™ Kidney

Jan 6, 2025, 4:05 PM EST - 1 year ago

Oncocyte Expands Market Opportunity for VitaGraft™ Kidney


Insight Molecular Diagnostics Earnings Call Transcript: Q1 2024

May 15, 2024, 4:30 PM EDT - 2 years ago

Insight Molecular Diagnostics Earnings Call Transcript: Q1 2024


Oncocyte Reports First Quarter 2024 Financial Results

May 15, 2024, 4:05 PM EDT - 2 years ago

Oncocyte Reports First Quarter 2024 Financial Results


Insight Molecular Diagnostics Earnings Call Transcript: Q4 2023

Apr 12, 2024, 8:00 AM EDT - 2 years ago

Insight Molecular Diagnostics Earnings Call Transcript: Q4 2023


Oncocyte Reports Full Year 2023 Financial Results

Apr 12, 2024, 6:00 AM EDT - 2 years ago

Oncocyte Reports Full Year 2023 Financial Results


Insight Molecular Diagnostics Earnings Call Transcript: Q2 2023

Aug 10, 2023, 8:00 AM EDT - 2 years ago

Insight Molecular Diagnostics Earnings Call Transcript: Q2 2023


Oncocyte Announces 1-For-20 Reverse Stock Split

Jul 24, 2023, 1:35 PM EDT - 3 years ago

Oncocyte Announces 1-For-20 Reverse Stock Split


Oncocyte Begins Manufacturing Transplant Blood Test

Jun 27, 2023, 8:30 AM EDT - 3 years ago

Oncocyte Begins Manufacturing Transplant Blood Test


Insight Molecular Diagnostics Earnings Call Transcript: Q1 2023

May 11, 2023, 9:00 AM EDT - 3 years ago

Insight Molecular Diagnostics Earnings Call Transcript: Q1 2023


Oncocyte Reports First Quarter 2023 Financial Results

May 11, 2023, 8:00 AM EDT - 3 years ago

Oncocyte Reports First Quarter 2023 Financial Results


Oncocyte To Announce First Quarter 2023 Financial Results

Apr 27, 2023, 4:59 PM EDT - 3 years ago

Oncocyte To Announce First Quarter 2023 Financial Results


Oncocyte Presents New Data at AACR

Apr 18, 2023, 8:45 AM EDT - 3 years ago

Oncocyte Presents New Data at AACR


Oncocyte Announces Reduction in Force

Apr 12, 2023, 4:15 PM EDT - 3 years ago

Oncocyte Announces Reduction in Force


jackedmund99
jackedmund99 May. 5 at 5:52 PM
$IMDX Refinitiv/Verus is a high-performing, quantitative independent research firm- this clown firm put a sale on Stock yesterday while it was going up a dollar it’s a quantitative research company. They have no foresight no intuition. They look at everything from quantitative analytical viewpoint obviously not doing a deep dive not talking to anybody just purely odd numbers so in the grand scheme of things they’re irrelevant.
0 · Reply
jackedmund99
jackedmund99 May. 5 at 5:48 PM
$IMDX huge volume yesterday whoever’s buying is letting it drift down and the little guys get out. Let let it fall. I believe they’ll be back closer to 4 1/4.
0 · Reply
WarrenPsnik
WarrenPsnik May. 5 at 2:23 PM
$IMDX Starter at $4.80 … (25%), long. Will look to add more on weakness (if there is) eyeing closer to $4.20 average
0 · Reply
StockScanners
StockScanners May. 5 at 5:25 AM
$IMDX keep watch if this holds above 4.98
0 · Reply
RUNNINWILD
RUNNINWILD May. 5 at 4:26 AM
$IMDX https://stocks.apple.com/AVpkzXASkQLalf1EDJGT4bg
0 · Reply
RUNNINWILD
RUNNINWILD May. 5 at 4:20 AM
$IMDX steady now, lads
0 · Reply
topstockalerts
topstockalerts May. 4 at 8:31 PM
$IMDX this is quietly putting in work while everything else chops
0 · Reply
RETAlerts
RETAlerts May. 4 at 8:29 PM
Interesting timing on $IMDX. HVAC content strategy gaining traction, catalyst driving the move. +5.2% on real engagement metric...
0 · Reply
Bogwood
Bogwood May. 4 at 8:16 PM
$IMDX such a solid close!! Highest vol since the times square rebranding day
0 · Reply
InvestingSpaceman
InvestingSpaceman May. 4 at 7:40 PM
$MNDR $CCM $IMDX why not
0 · Reply
Logic102
Logic102 May. 4 at 4:07 PM
$IMDX There seems to be a Whale or two quite willing to pay over 20% above an already bolstered up recent share price from today's open after a large Insider Buy recently. Connect the dots.
0 · Reply
ChipDistribution7
ChipDistribution7 May. 4 at 3:55 PM
$IMDX ~$3.8, ~$135M mcap, now a catalyst-driven reset setup rather than a broken biotech. Broadwood (~40%) keeps adding even above prior $5.75 raise levels — usually a strong signal of long-horizon conviction into Q3 2026 regulatory window. Core shift: transplant rejection monitoring moving from invasive biopsies → blood-based donor DNA testing. Science is largely validated, now it’s execution + adoption. Key edge is distribution: kit-based model embedded into existing Bio-Rad ($BIO) PCR infrastructure across hospitals, not centralized labs. <150 days to major catalyst. Approval odds ~70% on diagnostic pathway. If adoption hits → asymmetric rerating (3–10x potential). If not → it stays a delayed turnaround story. Follow me 👉@ChipDistribution7 for real-time updates and everything. Let’s make moves!
0 · Reply
jackedmund99
jackedmund99 May. 4 at 3:27 PM
$IMDX 670,000 shares whose buying ?
1 · Reply
SmartMoneyTradez
SmartMoneyTradez May. 4 at 3:12 PM
$IMDX 50 ma cross
1 · Reply
Logic102
Logic102 May. 4 at 2:49 PM
$IMDX Wow, looking extremely strong the last several days. Anything new today?
0 · Reply
Bogwood
Bogwood May. 3 at 6:29 AM
$IMDX I think we're going to see a surge in IQ sales this upcoming earnings in a couple weeks. Only $30K in lab service sales this Q, but A/R was over $1M as of Dec.
0 · Reply
Bogwood
Bogwood May. 1 at 5:49 AM
$IMDX Over 8M shares traded this month. Others are finally starting to see the vision... 🤩💹🧬📦
0 · Reply
BillionerOfKing
BillionerOfKing Apr. 30 at 3:31 PM
$IMDX Current Stock Price: $3.97 Contracts to trade: $4.0 IMDX May 15 2026 Call Entry: $0.76 Exit: $1.13 ROI: 49% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
jackedmund99
jackedmund99 Apr. 29 at 1:03 AM
$IMDX reality Broadwood cap And Neil Bradshear on close to 40% of the company entirely that’s more than 10% 
0 · Reply
Bogwood
Bogwood Apr. 28 at 8:24 PM
$IMDX Look at this pivot guys!!!! Incumbant $CDNA CareDx last week sold off their HLA/ddcf-DNA kit biz, and then used that cash to buy another MRD/cancer diag biz. They've all but folded their transplant hand accepting they're checkmated when it comes to GraftAssure in '27 https://investors.caredx.com/news/news-details/2026/CareDx-Announces-Agreement-to-Acquire-Naveris-A-Leader-in-Viral-Mediated-Cancer-MRD-Surveillance-Testing/default.aspx
0 · Reply
G101SPM
G101SPM Apr. 28 at 2:30 PM
#INSIDERS $EFOR Chief Financial Officer and three (3) Directors bought 13,218 shares combined worth approximately $260K (transaction dates were 4/27). $IMDX 10% owner Broadwood Partners bought 570,184 shares at $3.39 - $3.84 worth approximately $2.0 mln (transaction dates 4/23-4/27). $KREF Chief Executive Officer and the President, COO and Secretary bought 100,000 shares combined at $5.99 - $6.09 worth approximately $604K (transaction dates were 4/24). $WASH Senior Executive Vice President and Chief Commercial Banking bought 32,000 shares at $30.42 - $31.57 worth approximately $998K (transaction date 4/23).
0 · Reply
Logic102
Logic102 Apr. 28 at 2:06 PM
$IMDX and LCTX Looks like Neil Bradsher and Broadwood can afford Steak and Lobster on their new Yacht today.
0 · Reply